Mackenzie Financial Corp Boosts Stake in AdaptHealth Corp. (NASDAQ:AHCO)

Mackenzie Financial Corp boosted its position in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 111.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 81,583 shares of the company's stock after acquiring an additional 43,059 shares during the period. Mackenzie Financial Corp owned 0.06% of AdaptHealth worth $777,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Principal Financial Group Inc. raised its holdings in shares of AdaptHealth by 204.0% during the fourth quarter. Principal Financial Group Inc. now owns 1,652,765 shares of the company's stock worth $15,735,000 after purchasing an additional 1,109,021 shares during the last quarter. Segall Bryant & Hamill LLC raised its holdings in shares of AdaptHealth by 29.8% during the fourth quarter. Segall Bryant & Hamill LLC now owns 4,803,981 shares of the company's stock worth $45,734,000 after purchasing an additional 1,102,173 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of AdaptHealth by 17.6% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,379,715 shares of the company's stock worth $32,174,000 after purchasing an additional 505,180 shares during the last quarter. Bridgeway Capital Management LLC grew its position in AdaptHealth by 27.2% during the fourth quarter. Bridgeway Capital Management LLC now owns 1,324,043 shares of the company's stock valued at $12,605,000 after buying an additional 283,143 shares during the period. Finally, Royce & Associates LP grew its position in AdaptHealth by 29.0% during the fourth quarter. Royce & Associates LP now owns 1,002,755 shares of the company's stock valued at $9,546,000 after buying an additional 225,350 shares during the period. Hedge funds and other institutional investors own 82.67% of the company's stock.

AdaptHealth Price Performance

Shares of NASDAQ AHCO traded up $0.16 during trading on Thursday, hitting $9.02. The company had a trading volume of 1,104,807 shares, compared to its average volume of 1,291,055. The stock has a fifty day simple moving average of $8.83 and a two-hundred day simple moving average of $9.57. AdaptHealth Corp. has a fifty-two week low of $7.11 and a fifty-two week high of $11.90. The firm has a market capitalization of $1.22 billion, a price-to-earnings ratio of -5.47, a price-to-earnings-growth ratio of 1.08 and a beta of 1.64. The company has a quick ratio of 1.00, a current ratio of 1.24 and a debt-to-equity ratio of 1.34.

Analysts Set New Price Targets

Several analysts recently commented on AHCO shares. Canaccord Genuity Group raised their price target on shares of AdaptHealth from $13.00 to $14.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Robert W. Baird raised their price target on shares of AdaptHealth from $14.00 to $16.00 and gave the company an "outperform" rating in a research report on Thursday, February 27th. Royal Bank of Canada dropped their price target on shares of AdaptHealth from $14.00 to $13.00 and set an "outperform" rating on the stock in a research report on Thursday, May 8th. UBS Group dropped their price target on shares of AdaptHealth from $12.00 to $11.00 and set a "buy" rating on the stock in a research report on Thursday, February 13th. Finally, Truist Financial dropped their price target on shares of AdaptHealth from $14.00 to $13.00 and set a "buy" rating on the stock in a research report on Monday, May 12th. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, AdaptHealth currently has an average rating of "Buy" and an average price target of $13.40.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.